scispace - formally typeset
N

Nilgun Tasdemir

Researcher at University of Pittsburgh

Publications -  30
Citations -  1824

Nilgun Tasdemir is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Invasive lobular carcinoma & Cancer. The author has an hindex of 17, co-authored 30 publications receiving 1320 citations. Previous affiliations of Nilgun Tasdemir include Memorial Sloan Kettering Cancer Center & Cold Spring Harbor Laboratory.

Papers
More filters
Journal ArticleDOI

BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance

TL;DR: This study reveals how cells undergoing oncogene-induced senescence acquire a distinctive enhancer landscape that includes formation of super-enhancers adjacent to immune-modulatory genes required for paracrine immune activation.
Journal ArticleDOI

The histone chaperone CAF-1 safeguards somatic cell identity

TL;DR: The findings reveal the histone chaperone CAF-1 to be a novel regulator of somatic cell identity during transcription-factor-induced cell-fate transitions and provide a potential strategy to modulate cellular plasticity in a regenerative setting.
Journal ArticleDOI

Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells

TL;DR: Differential expression of Wnt ligands in HCC cells is associated with selective activation of canonical Wnt signaling in well-differentiated, and its repression in poorly differentiated cell lines, which support the hypothesis that Wnt pathway is selectively activated or repressed depending on differentiation status of H CC cells.
Journal ArticleDOI

Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function.

TL;DR: It is reported that the epigenetic reader BRD4 and the methyltransferase G9a repress a TFEB/TFE3/MITF-independent transcriptional program that promotes autophagy and lysosome biogenesis, and is directed independently and also reciprocally to the growth-promoting properties ofBRD4.
Journal ArticleDOI

Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition

TL;DR: It is shown that strong suppression of the BET protein Brd4 in adult animals has dramatic effects in multiple tissues, and several potential outcomes associated with potent and sustained BET protein inhibition are predicted.